This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alderson, L. M. Articles by Henson, J. W. Search for Related Content PubMed PubMed Citation Articles by Alderson, L. M. Articles by Henson, J. W.

Human Gliomas with Wild-Type p53 Express bcl-2¹

Molecular Neuro-Oncology Laboratory, Neurology Service [L. M. A., R. L. C., J. W. H.], Neurosurgery Service [G. R. H., D. N. L.], Department of Pathology (Neuropathology) [D. N. L.], and Harvard Medical School [G. R. H., D. N. L., J. W. H.], Massachusetts General Hospital, Charlestown, Massachusetts 02129

Human astrocytomas frequently overexpress wild-type p53, which suggests that gliomas have evolved a mechanism to subvert p53-mediated apoptosis. bcl-2 inhibits apoptosis mediated by p53, and it is expressed in several human cancers. We therefore examined a series of human gliomas to determine whether bcl-2 is expressed and whether this expression is associated with tumors which have wild-type p53. Twenty-eight paraffinembedded gliomas (3 WHO grade II, 13 grade III, 12 grade IV) were immunohistochemically stained for bcl-2 and p53. p53 mutations were identified with single strand conformation polymorphism and DNA sequencing. Sixteen of 28 (57%) tumors expressed bcl-2, and bcl-2 expression was associated with wild-type p53 (P < 0.01). Among gliomas which overexpressed p53, bcl-2 was positive in 7 of 7 tumors with wild-type p53 but in only 1 of 7 with mutant p53 (P < 0.01). We conclude that bcl-2 is frequently expressed in human gliomas and that expression is more common in tumors with wild-type p53.

¹ Supported by NIH Grants NS 01605 (J. W. H.) and CA 57683 (D. N. L.).

² To whom requests for reprints should be addressed, at Molecular Neuro-Oncology Laboratory, CNY6, Massachusetts General Hospital, Charlestown, MA 02129.

Received 11/14/94. Accepted 1/18/95.

This article has been cited by other articles:

				P. Vigano, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis Hum. Reprod. Update, January 1, 2006; 12(1): 77 - 89. [Abstract] [Full Text] [PDF]

				C. Gomez-Manzano, P. Mitlianga, J. Fueyo, H.-Y. Lee, M. Hu, K. B. Spurgers, T. L. Glass, D. Koul, T.-J. Liu, T. J. McDonnell, et al. Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2 Cancer Res., September 1, 2001; 61(18): 6693 - 6697. [Abstract] [Full Text] [PDF]

				T. Shono, P. J. Tofilon, J. M. Bruner, O. Owolabi, and F. F. Lang Cyclooxygenase-2 Expression in Human Gliomas: Prognostic Significance and Molecular Correlations Cancer Res., June 1, 2001; 61(11): 4375 - 4381. [Abstract] [Full Text] [PDF]

				M. Mizoguchi, T. Inamura, T. Shono, K. Ikezaki, S. Inoha, S. Ohgami, and M. Fukui A comparative study of apoptosis and proliferation in germinoma and glioblastoma Neuro-oncol, April 1, 2000; 2(2): 96 - 102. [Abstract] [PDF]

				W.-Y. Chan, K.-K. Cheung, J. O. Schorge, L.-W. Huang, W. R. Welch, D. A. Bell, R. S. Berkowitz, and S. C. Mok Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers Am. J. Pathol., February 1, 2000; 156(2): 409 - 417. [Abstract] [Full Text] [PDF]

				H Strik, M Deininger, J Streffer, E Grote, J Wickboldt, J Dichgans, M Weller, and R Meyermann BCL-2 Family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 763 - 768. [Abstract] [Full Text] [PDF]

				L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17beta -Estradiol in Breast Cancer Cells J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107. [Abstract] [Full Text] [PDF]

				H. W. Findley, L. Gu, A. M. Yeager, and M. Zhou Expression and Regulation of Bcl-2, Bcl-xl, and Bax Correlate With p53 Status and Sensitivity to Apoptosis in Childhood Acute Lymphoblastic Leukemia Blood, April 15, 1997; 89(8): 2986 - 2993. [Abstract] [Full Text] [PDF]